(1)
Jeesa George. Pharmacovigilance During Pre-Approval Phases -Comparison of ICH E2E, CIOMS VI, FDA, EMEA/CHMP and CDSCO Risk Management Guidelines. IJPRSE 2022, 3, 80-86.